Skip to Content

GPI 250 mg 907 (Penicillamine 250 mg)

Pill with imprint GPI 250 mg 907 is White, Capsule-shape and has been identified as Penicillamine 250 mg. It is supplied by Granules Pharmaceuticals Inc..

Penicillamine is used in the treatment of wilson's disease; cystinuria; rheumatoid arthritis and belongs to the drug class antirheumatics. There is positive evidence of human fetal risk during pregnancy. Penicillamine 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for GPI 250 mg 907

Penicillamine

Imprint
GPI 250 mg 907
Strength
250 mg
Color
White
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Antirheumatics
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Granules Pharmaceuticals Inc.
National Drug Code (NDC)
70010-0907

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.